AI assistant
Sending…
MYRIAD GENETICS INC — Director's Dealing 2018
Jun 19, 2018
32566_dirs_2018-06-19_5ce747b1-7134-4b99-bd58-7604b33763ab.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: MYRIAD GENETICS INC (MYGN)
CIK: 0000899923
Period of Report: 2018-06-18
Reporting Person: MARSH RICHARD M (E.V.P., General Counsel)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2018-06-18 | Common Stock | M | 33000 | $30.34 | Acquired | 157197 | Direct |
| 2018-06-18 | Common Stock | S | 33000 | $40.0 | Disposed | 124197 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2018-06-18 | Non-Qualified Stock Option (right to buy) | $30.34 | M | 33000 | Disposed | 2019-09-15 | Common Stock (33000) | Direct |
Footnotes
F1: This transaction was effected pursuant to a Rule 10b5-1 trading plan.
More from MYRIAD GENETICS INC
Interim / Quarterly Report
2026
May 6
Regulatory Filings
2026
May 5
Annual Report
2026
Apr 14
Proxy Solicitation & Information Statement
2026
Apr 14
Proxy Solicitation & Information Statement
2026
Apr 14
Major Shareholding Notification
2026
Apr 7
Major Shareholding Notification
2026
Mar 27
Regulatory Filings
2026
Mar 5
Regulatory Filings
2026
Mar 4
Director's Dealing
2026
Mar 2